ICD10 code of Opsoclonus myoclonus syndrome and ICD9 code

Opsoclonus myoclonus syndrome (OMS) is primarily classified under ICD-10 code G62.89 (Other specified polyneuropathies) or sometimes coded under G25.3 (Myoclonus), depending on the specific clinical presentation and underlying etiology. In the older ICD-9-CM classification system, Opsoclonus myoclonus syndrome was most commonly represented by code 333.2 (Myoclonus).

What is the clinical nature of Opsoclonus myoclonus syndrome?

Opsoclonus myoclonus syndrome, often referred to as "dancing eyes-dancing feet syndrome," is a rare, immune-mediated neurological disorder. It is characterized by chaotic, multi-directional eye movements (opsoclonus), involuntary muscle jerks (myoclonus), and often ataxia (balance issues), irritability, and sleep disturbances. Because Opsoclonus myoclonus syndrome is frequently a paraneoplastic condition—meaning it occurs as an immune response to a hidden tumor, such as neuroblastoma in children—early diagnosis and precise coding are critical for guiding appropriate oncology and neurology screenings.

How is Opsoclonus myoclonus syndrome categorized for medical billing?

Medical coding for Opsoclonus myoclonus syndrome can be complex because the syndrome is a clinical manifestation rather than a single disease entity. Clinicians often use a combination of codes to capture the full picture:

• ICD-10-CM G62.89: Often used to denote the paraneoplastic nature of the neurological symptoms.


• ICD-10-CM G25.3: Specifically captures the myoclonus component.


• ICD-10-CM H57.8: Sometimes used to document the opsoclonus (eye movement) aspect.


• ICD-9-CM 333.2: The historical standard that encompassed various forms of myoclonus, including those associated with Opsoclonus myoclonus syndrome.

Why is accurate diagnosis important for patients?

For the 7 members of the DiseaseMaps.org community living with this condition, understanding that Opsoclonus myoclonus syndrome requires a multidisciplinary approach is vital. The diagnostic journey often involves searching for an underlying malignancy, particularly neuroblastoma in pediatric cases or small-cell lung cancer in adults. Because this is an immune-mediated condition, treatment usually involves aggressive immunotherapy (such as corticosteroids, IVIG, or rituximab) alongside the treatment of any identified tumor. Navigating the healthcare system with a rare diagnosis like Opsoclonus myoclonus syndrome can be isolating, which is why connecting with others who understand the clinical nuances is so valuable.

What should you do if you suspect a diagnosis?

If you or a loved one are experiencing symptoms consistent with Opsoclonus myoclonus syndrome, prompt evaluation by a neurologist is essential. Because of the rarity of the condition, seeking care at a tertiary academic medical center with experience in paraneoplastic syndromes is highly recommended.

Next steps

• Consult a pediatric or adult neurologist specializing in neuro-immunology or movement disorders.


• Request comprehensive imaging (MRI, PET/CT) to rule out underlying occult malignancies.


• Connect with the Opsoclonus myoclonus syndrome community at DiseaseMaps.org to share experiences and coping strategies.


• Inquire about clinical trials or registry studies through the NIH GARD portal to support ongoing research.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH GARD (Genetic and Rare Diseases Information Center): Information on Opsoclonus Myoclonus Syndrome.


• Orphanet: ORPHA652: Opsoclonus-myoclonus syndrome.


• OMIM (Online Mendelian Inheritance in Man): #164600 (Opsoclonus-myoclonus syndrome).


• PubMed: Clinical reviews on the paraneoplastic etiology of Opsoclonus myoclonus syndrome.